1. Home
  2. OBIO vs BOOM Comparison

OBIO vs BOOM Comparison

Compare OBIO & BOOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBIO
  • BOOM
  • Stock Information
  • Founded
  • OBIO 2017
  • BOOM 1965
  • Country
  • OBIO United States
  • BOOM United States
  • Employees
  • OBIO N/A
  • BOOM N/A
  • Industry
  • OBIO Medicinal Chemicals and Botanical Products
  • BOOM Industrial Specialties
  • Sector
  • OBIO Health Care
  • BOOM Industrials
  • Exchange
  • OBIO Nasdaq
  • BOOM Nasdaq
  • Market Cap
  • OBIO 151.3M
  • BOOM 130.3M
  • IPO Year
  • OBIO N/A
  • BOOM N/A
  • Fundamental
  • Price
  • OBIO $2.85
  • BOOM $6.47
  • Analyst Decision
  • OBIO Strong Buy
  • BOOM Buy
  • Analyst Count
  • OBIO 5
  • BOOM 2
  • Target Price
  • OBIO $15.00
  • BOOM $16.50
  • AVG Volume (30 Days)
  • OBIO 69.1K
  • BOOM 209.0K
  • Earning Date
  • OBIO 05-12-2025
  • BOOM 05-01-2025
  • Dividend Yield
  • OBIO N/A
  • BOOM N/A
  • EPS Growth
  • OBIO N/A
  • BOOM N/A
  • EPS
  • OBIO N/A
  • BOOM N/A
  • Revenue
  • OBIO $2,638,000.00
  • BOOM $642,851,000.00
  • Revenue This Year
  • OBIO $27.37
  • BOOM N/A
  • Revenue Next Year
  • OBIO $42.68
  • BOOM $5.30
  • P/E Ratio
  • OBIO N/A
  • BOOM N/A
  • Revenue Growth
  • OBIO N/A
  • BOOM N/A
  • 52 Week Low
  • OBIO $2.49
  • BOOM $6.02
  • 52 Week High
  • OBIO $8.87
  • BOOM $17.22
  • Technical
  • Relative Strength Index (RSI)
  • OBIO 36.86
  • BOOM 33.24
  • Support Level
  • OBIO $2.75
  • BOOM $6.10
  • Resistance Level
  • OBIO $3.26
  • BOOM $6.64
  • Average True Range (ATR)
  • OBIO 0.48
  • BOOM 0.60
  • MACD
  • OBIO -0.01
  • BOOM -0.13
  • Stochastic Oscillator
  • OBIO 16.82
  • BOOM 15.68

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About BOOM DMC Global Inc.

DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.

Share on Social Networks: